Description
Platelet Factor 4
| Catalog number: | B2014088 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 0.1 mg |
| Molecular Weight or Concentration: | 29 kDa |
| Supplied as: | Powder |
| Applications: | molecular tool for various biochemical applications |
| Storage: | 2-8C |
| Keywords: | Platelet Factor 4 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kimura A. [Platelet factor 4] Nihon Rinsho. 1999 Sep;57 Suppl:702-4.
- Wang Z, Huang H. Platelet_factor-4 (CXCL4/PF-4): an angiostatic chemokine for cancer therapy Cancer Lett. 2013 May 1;331(2):147-53.
- Arepally GM. Heparin-induced thrombocytopenia Blood. 2017 May 25;129(21):2864-2872.
- Bikfalvi A. Platelet_factor 4: an inhibitor of angiogenesis Semin Thromb Hemost. 2004 Jun;30(3):379-85.
- Slungaard A. Platelet_factor 4 modulation of the thrombomodulin-protein C system Crit Care Med. 2004 May;32(5 Suppl):S331-5.
- Thachil J. The prothrombotic potential of platelet_factor 4 Eur J Intern Med. 2010 Apr;21(2):79-83.
- Kaplan KL, Owen J. Plasma levels of beta-thromboglobulin and platelet_factor_4 as indices of platelet activation in vivo Blood. 1981 Feb;57(2):199-202.
- Kowalska MA, Rauova L, Poncz M. Role of the platelet_ chemokine platelet factor 4 (PF4) in hemostasis and thrombosis Thromb Res. 2010 Apr;125(4):292-6.
- Cella G, Scattolo N, Girolami A, Sasahara AA. Are platelet_factor 4 and beta-thromboglobulin markers of cardiovascular disorders? Ric Clin Lab. 1984 Jan-Mar;14(1):9-18.
